The Pulmonary adenoma resistance 2 (Par2) locus of the BALB/cByJ mouse, located within 0.5 cM of chromosome 18, is responsible for reducing the mean multiplicity of urethane-induced lung tumors relative to those in C57BL/ 6J, A/J and C3H/HeJ mice. Thus, BALB/B6-Par2 congenic strain genetically identical to BALB/cByJ except carrying C57BL/6J Par2 alleles develops seven times more tumors than BALB/cByJ. To gain clues for identification of Par2 candidate genes, we analysed lung tumorigenesis in BALB/cByJ2BALB.B6-Par2 chimeric animals. Of 100 tumors induced by urethane in 16 chimeras, 82 originated from BALB.B6-Par2 cells, indicating the Par2 phenotype to be cell-autonomous. In addition, the BALB.B6-Par2-and BALB/cByJ-derived tumors were similar in mean size, implying that the phenotype is primarily expressed during initiation rather than in the promotion stage of carcinogenesis. Given these results, we surveyed a comprehensive mouse genome database and physically mapped Par2 within a 2.3 Mbp segment containing three known genes, Polı, Mbd2 and Dcc. Among those, the Polı seemed to be the most reasonable Par2 candidate, since it encodes an extremely error-prone DNA polymerase preferentially incorporating G or T opposite template T in vitro, reminiscent of the Kras2 activation because of an A to G or T point mutation within codon 61 with which most urethane-induced lung tumors are initiated. Indeed, our sequencing of Polı cDNAs from BALB/cByJ, C57BL/6J, A/J and C3H/ HeJ lungs revealed 21 BALB/cByJ-specific single-nucleotide polymorphisms in the coding region accompanied by seven amino-acid substitutions and an elevated frequency of alternative splicing, while no polymorphisms associated with tumor susceptibility were found for either Mbd2 or Dcc. Notably, we obtained evidence that BALB/cByJ Par2 alleles may selectively decrease the frequency of Kras2-mutated tumors compared with C57BL/6J alleles. Consequently, the Polı is an intriguing Par2 candidate clearly deserving further evaluation.
Introduction
In terms of the mean multiplicity of lung tumors induced by urethane, laboratory mouse strains have been categorized into sensitive, intermediate and resistant groups (Malkinson and Beer, 1983) . The A/J (A) mouse strain belongs to the sensitive group with at least 20 times higher susceptibility than resistant strains like C57BL/6J (B6) and C3H/HeJ (C3H). The difference is largely determined by the Pulmonary adenoma susceptibility 1 (Pas1) locus on chromosome 6, the sensitive A allele of which is phenotypically dominant in F 1 progeny of A and C3H (Gariboldi et al., 1993) or B6 (Devereux et al., 1994; Festing et al., 1994) mice. There is evidence that the Pas1 gene could be identical to the Kras2 oncogene. Activation of Kras2 because of point mutation is common in both mouse and human lung tumors. You et al. (1992) found that, in lung tumors developing in F 1 mice from crosses between A and C3H, the A allele of Kras2 was preferentially activated. They further demonstrated it to be more expressed than the C3H allele in F 1 lung tumors, the difference being apparently because of polymorphism in the second intron (Chen et al., 1994) . The A and C3H alleles have been designated K s and K r , respectively, and genotyping of many laboratory mouse strains has revealed that most resistant strains, including B6, carry the K r allele. Conversely, strains with the K s allele are generally susceptible to lung carcinogenesis, providing support for the conclusion that the Kras2 oncogene may be Pas1.
ONCOGENOMICS
The BALB/cByJ (BALB) strain is 14 times less susceptible than the A strain to lung tumorigenesis and is thus regarded as a member of the intermediate group. In (A Â BALB)F 1 mice, the relatively resistant BALB phenotype, unlike the full resistance of C3H and B6, is semidominant over the high sensitivity of A, indicating the existence of a dominant lung tumor resistance gene(s) that can suppress the A phenotype (Malkinson and Beer, 1983) . In fact, we identified a single major resistance locus on chromosome 18 of BALB mice, designated Pulmonary adenoma resistance 2 (Par2), by analysing (A Â BALB)F 1 Â A backcross animals (Obata et al., 1996) . The tumor-resistant phenotype is unique for the BALB Par2 allele. While the C3H and B6 Par2 alleles are not phenotypically discernable from the A Par2 allele, by analysing (C3H Â BALB)F 1 Â C3H backcross mice, we elucidated that BALB mice carry the A allele of Pas1, whose phenotype is partly suppressed by the resistant BALB Par2 allele, resulting in an overall intermediate phenotype (Karasaki et al., 1997) . Interestingly, the BALB Kras2 allele is also known to be K s . Our primary goal is to positionally clone the Par2 locus, although it is a very difficult task because of quantitative nature of the Par2 phenotype. Utilizing a congenic mouse strain, BALB.B6-Par2, which is genetically identical to BALB except for carrying the Par2-containing, 25 cM segment of chromosome 18 from B6, we recently succeeded in finely mapping Par2 within a 0.5 cM chromosomal section flanked by the D18Mit103 and D18Mit188 microsatellites (Lee et al., 2001) . We now intend to proceed to identify the Par2 gene through combined positional and candidate gene approaches. However, candidates must be carefully selected from the known genes located within Par2 with reference to biological features of the Par2 phenotype. In particular, knowledge on its cell-autonomy and stage-specific involvement regarding initiation or promotion of carcinogenesis should greatly aid the selection procedure.
BALB.B6-Par2 congenic mice develop approximately seven times more lung tumors on exposure to urethane than do parental BALB mice, solely because of the allelic difference at the Par2 locus. To gain clues for selecting Par2 candidate genes, we therefore analysed lung tumorigenesis in BALB2BALB.B6-Par2 chimeric mice. Since both BALB and BALB.B6-Par2 cells are placed into the same environment in such chimeras, cellautonomous action of the Par2 must result in the excess of BALB.B6-Par2 tumors. Moreover, if the phenotype is cell-autonomous, involvement in initiation or promotion would result, respectively, in equivalence or difference in mean size of BALB-and BALB.B6-Par2-derived tumors.
In the present study, we demonstrate that the Par2 acts cell-autonomously during the initiation stage of carcinogenesis and suggest Polı gene, encoding an errorprone DNA polymerase (Johnson et al., 2000; Tissier et al., 2000b; Zhang et al., 2000a ) , as an intriguing candidate for Par2.
Results

Lung tumor development in BALB and BALB/B6-Par2 mice
Male and female BALB, (BALB Â BALB.B6-Par2)F 1 and BALB.B6-Par2 mice were treated with urethane and killed 4 months thereafter. BALB.B6-Par2 is a congenic strain genetically identical to BALB/cByJ except carrying B6 Par2 alleles. As shown in Table 1 , BALB.B6-Par2 mice developed approximately seven times more lung tumors than the BALB mice, confirming the effect of Par2 on lung tumor susceptibility. (BALB Â BALB.B6-Par2)F 1 mice exhibited an intermediate susceptibility, indicating additive effects of the BALB allele on tumor resistance. No remarkable sex differences were observed with these phenomena. Similarly, when male BALB and BALB.B6-Par2 mice were treated with diethylnitrosamine (DEN), assessment after 4 months revealed BALB.B6-Par2 mice to develop two times more tumors than BALB mice (Table 1) . Thus, the BALB Par2 also endows resistance against DEN, though the effect appears smaller than that with urethane as the carcinogen.
Lung tumors developing in chimeric mice
BALB2BALB.B6-Par2 chimeric mice were treated with urethane and killed 6 months thereafter. Polymerase chain reaction (PCR) genotyping of the D18Mit49 microsatellite, which is linked to Par2 and polymorphic between BALB and BALB.B6-Par2, was used for determination of the strain-origin of each lung tumor and the proportion of BALB and BALB.B6-Par2 cells in each nontumorous sample of the chimeric lung tissue. This was possible because we confirmed in advance that none of the 20 urethane-induced lung tumors from (BALB Â BALB.B6-Par2)F 1 mice featured loss of heterozygosity at the D18Mit49 locus (data not shown). Representative results for electrophoresed D18Mit49 PCR products and a summary of the results are shown in Figure 1 and Table 2 , respectively. The 16 chimeric mice developed 103 lung tumors in total, with a mean multiplicity of 6.4. There was a significant, negative correlation between tumor multiplicity and the proportion of BALB cells in nontumorous lung tissue (P ¼ 0.025) and of all the tumors, 82 were found to be derived from BALB.B6-Par2 cells, while only 18 were from BALB cells. The origin of the remaining three tumors was undeterminable because of their small size. To test the statistical significance of the results, a Pvalue was calculated by the one-sided binominal test for each chimera in consideration of the estimated percentage of BALB cells in the normal lung. The null hypothesis was that the probability of a BALB cell developing into a detectable lung tumor is not smaller than that of a BALB.B6-Par2 cell. The overall P-value obtained by combining individual P-values of 16 chimeras was highly significant (P ¼ 2 Â 10 À5 ), indicating that the probability of a BALB cell developing into a tumor is smaller than that of a BALB.B6-Par2 cell. Thus, the lung-tumor-resistant phenotype of the BALB Par2 was concluded to be essentially cell-autonomous. We also compared mean diameters of BALB-and BALB.B6-Par2-derived tumors, but they were similar (1.5470.19 mm for BALB and 1.6070.09 mm for BALB.B6-Par2 (Mean7s.e.), P ¼ 0.36). Thus, Par2 significantly affects the tumor number, but not the size, and is likely to be involved in initiation, rather than in the promotion stage of carcinogenesis.
Physical mapping of the Par2 locus and cDNA sequences of candidate genes
Guided by the information obtained with the chimera experiment, we aimed to disclose the molecular identity of the responsible gene in the Par2 locus employing a combined positional and candidate gene approach. We previously showed that Par2 exists between two critical recombination break points each carried by the R 7 B10 or R 7 B7 mouse originating from a BALB Â (BALB Â BALB.B6-Par2)F 1 cross (Lee et al., 2001) . The closest proximal and distal microsatellites flanking the interval are D18Mit103 and D18Mit188, respectively. To select Par2 candidate genes with reference to positional information, we here build a physical map using the Celera Discovery System and Celera's associated databases ( Figure 2 ). The Par2 region is at most 2.3 Mb in physical length and contains three known genes, Polı, a DNA polymerase gene (McDonald et al., 1999) , Mbd2, a methyl-CpG binding domain protein gene (Hendrich and Bird, 1998) and Dcc, a tumor-suppressor gene (Cooper et al., 1995) , together with a microsatellite, D18Mit186. We therefore determined the nucleotide sequences of the entire coding region of the three genes with cDNA samples of BALB, B6, A and C3H lung tissues. Considering the cell-autonomous involvement of Par2 in the initiation stage, we regarded Polı as a very plausible Par2 candidate since it encodes an extraordinarily error-prone DNA polymerase, preferentially incorporating G or T opposite template T (Johnson et al., 2000; Tissier et al., 2000b; Zhang et al., 2000a) . The fact that urethane-induced lung tumors are commonly initiated by Kras2 activations because of an A to G or T point mutation within codon 61 (Dragani et al., 1995) is clearly of interest in this context.
Sequencing of Polı cDNAs indeed revealed as many as 25 single-nucleotide polymorphism (SNP) sites within the open-reading frame consisting of 717 codons or 2.2 kbp (Table 3) . Notably, for 21 of these, BALB exhibited unique sequences. Among the BALB-specific SNPs, seven result in amino-acid substitution (Table 3 and Figure 3 ). Genomic sequencing of Polı of the R 7 B7 and R 7 B10 mice confirmed that Polı exists between their critical recombination breakpoints (Figure 2 ). Interestingly, an abnormal splicing pattern resulting in new exonic sequences for exon 4 was found to be elevated in BALB and (BALB Â BALB.B6-Par2)F 1 lungs (Figure 4) . This variant encodes a truncated protein lacking the motifs IV and V essential for polymerase activity (Figure 3 ) because of a frame shift by introducing a 32-bp exogenic sequence (Figure 4 ). There was a BALB-specific SNP within the 32 bp insertion possibly responsible for the elevated alternative splicing (Figure 4) . Quantification by densitometry confirmed that BALB and (BALB Â BALB.B6-Par2)F 1 exhibit, respectively, the highest and the second highest expression of the variant relative to the normal among the strains examined (Figure 4 ).
For Dcc, we found two C3H-specific SNPs at codons 895 (TAT for C3H and TAC for the others) and 986 Nucleotide and amino-acid sequences specifically seen in only one of the mouse strains are indicated by underlined bold letters
Analysis of lung tumorigenesis in chimeric mice G-H Lee et al (CTG for C3H and TTG for the others) in its 4.3 kbp coding region, but these do not result in amino-acid substitution. In the 1.2 kbp coding region of Mbd2, a B6-specific SNP at codon 117 causing an amino-acid substitution (GGC (Gly) in the B6 case and GTC (Val) for the others) was observed. Since the BALB Par2 allele exhibits a unique phenotype (Obata et al, 1996; Karasaki et al., 1997; Lee et al., 2001) , the data do not support either of these two genes as Par2 candidates.
Kras2 mutations in lung tumors
Kras2 point mutations have been considered common initiating events for mouse lung carcinogenesis (Dragani et al., 1995) . All known activating point mutations of the Kras2 codon 61 and 12 were therefore analysed in urethane-and DEN-induced lung tumors developing in male BALB or BALB.B6-Par2 mice. We particularly focused on A to G and A to T at the second position of codon 61, since among the reported activating Kras2 There is a BALB-specific SNP within the 32 bp insertion. A silver-stained denaturing acrylamide gel demonstrates RT-PCR products with primers Alter-F (5 0 -GAGAGACTTGGATTTGATGAAA-3 0 ) and -R (5 0 -ATCTGCGATC-CAACCACAAGT-3 0 ). Quantification of the signal ratios (variant/normal) indicates that BALB and (BALB Â BALB.B6-Par2)F 1 lungs exhibit, respectively, the highest and the second highest expression of the variant relative to the normal point mutations in mouse lung tumors, only these would be expected to be relevant considering the characteristic of Polı to erroneously incorporate G or T opposite template T. With urethane, such mutations were found to be very frequent in BALB.B6-Par2 tumors (97%) and slightly lower in BALB tumors (86%) (Table 4), although the difference was not significant (P ¼ 0.21). On the other hand, with DEN, the frequency was 79% for BALB.B6-Par2, but only 46% for BALB (P ¼ 0.013; Table 4 ). Thus, under some conditions, the BALB Par2 decreases the frequency of the codon 61-mutated lung tumors, consistent with the hypothesis that it is identical with Polı.
Selective semiquantitative reverse transcription (RT)-PCR of normal Polı mRNA from BALB and BALB. B6-Par2 mice
One possible mechanism that might explain why Polı would confer lung tumor resistance on BALB is that the transcription of the BALB Polı allele produces less functional protein than the other alleles. Since the Polı protein coded by variant mRNA should be nonfunctional because of truncation of the critical motifs, we quantified lung Polı mRNAs by semiquantitative RT-PCR with a selective primer design evading amplification of variant. b2-microglobulin (b2-MG) mRNA was also analysed as an internal control. Three mice each of the BALB and BALB.B6-Par2 strains were chosen for comparison to make the influence of unlinked genes negligible. Relative amounts of Polı mRNA normalized by the level of b2-MG mRNA were 1.03, 1.09, 0.84 for BALB (mean ¼ 0.99) and 2.24, 1.89 and 2.50 for BALB.B6-Par2. (mean ¼ 2.21), the difference being statistically significant (P ¼ 0.0031). However, total amount of mRNA (normal+variant) for Polı as well as the amounts of mRNAs for Dcc and Mbd2 was not significantly different in expression level between BALB and BALB.B6-Par2 lungs (data not shown).
Discussion
The present study of lung tumors induced by urethane in chimeras between BALB and BALB.B6-Par2 congenic mice, with distinct phenotypes solely because of an allelic difference in the Par2 locus (Lee et al., 2001) , clearly demonstrated the Par2 phenotype to be cellautonomous. In other words, the Par2 protein expressed in the target cell, but not other surrounding cells, determines the tumor susceptibility. Therefore, Par2 should be neither an endocrine growth factor nor a nonpulmonary carcinogen-metabolizing enzyme, because in those cases the general milieu would be affected. Furthermore, the similarity in mean size of BALBand BALB.B6-Par2-derived tumors supports the conclusion that Par2 modifies the sensitivity to initiation rather than promotion of two-stage carcinogenesis. It is thus unlikely to be a regulator of cell growth or apoptosis. Since lung tumor susceptibility is controlled by polygenes, only the use of BALB.B6-Par2 congenic mice enabled these conclusions to be reached.
Given the results gained by the experiment with chimeric mice, we focused on the molecular identity of the Par2 locus applying a combined positional and candidate gene approach. According to the positional information for Par2 obtained in our previous fine mapping study (Lee et al., 2001 ) and the Celera's comprehensive mouse genome database, we physically mapped Par2 within a 2.3 Mbp segment containing three known genes, Polı, Mbd2 and Dcc. All these candidates might clearly be cancer-related. Considering the cell-autonomous involvement of Par2 in the initiation stage, however, the Polı is the strongest candidate since it encodes an extremely error-prone DNA polymerase inducing mutations (Johnson et al., 2000; Tissier et al., 2000a; Zhang et al., 2000b) . In fact, with the Polı cDNA, we detected as many as 21 BALB-specific SNPs accompanied by amino-acid substitutions and alternative splicing, consistent with the unique phenotype of the BALB Par2 allele. On the other hand, no polymorphisms associated with tumor susceptibility were found for either Mbd2 or Dcc. (Zhang et al., 2000b) The Pol1 protein, which is thought to participate in translesion synthesis (Tissier et al., 2000a; Zhang et al., 2001) and/or base excision repair of DNA (Bebenek et al., 2001) , tends to incorporate G or T opposite template T rather than the correct base, A, at least in vitro (Johnson et al., 2000; Tissier et al., 2000b; Zhang et al., 2000a) . Such erroneous G or T incorporation is, respectively, up to 10 times more efficient than the correct incorporation, violating the Watson-Crick rule. It is noteworthy that most urethane-induced mouse lung tumors are initiated by activation of Kras2 oncogene because of A to G or T point mutations at the second position of codon 61 (Dragani et al., 1995) . Moreover, BALB Par2 has been shown to suppress phenotypic expression of the major lung-tumor-sensitivity gene, Pas1 (Karasaki et al., 1997) , whose candidate is Kras2 itself (You et al., 1992; Chen et al., 1994) . Hence, it is very tempting to conclude that allelic differences in Polı contribute to lung tumor susceptibility by affecting the probability of Kras2-dependent initiation.
As expected, in this study most urethane-induced tumors exhibited A to G or T mutations of Kras2 codon 61, although the incidence was slightly lower in BALB (86%) than in BALB.B6-Par2 (97%) mice. Unlike urethane, however, we observed that the frequency of Kras2 codon 61-mutated tumors was low in BALB mice treated with DEN (46%), being notably higher in BALB.B6-Par2 (79%). This suggests that the B6 Par2 allele selectively increased Kras2 codon 61-mutated tumors via elevation of the mutation risk and provides further evidence in support of the Polı candidacy. The apparently lower effect of Par2 on tumor multiplicity with DEN than with urethane might result from DEN often initiating lung tumors through non-Kras2 codon 61 routes (Manam et al., 1992) .
If the hypothesis that Polı is Par2 is correct, the BALB Polı allele should have a quantitative and/or qualitative defect in activity. Our semiquantitative RT-PCR study indeed showed that the expression level of Polı mRNA coding for putatively functional proteins (normal) in BALB lungs was less than half that in BALB.B6-Par2 lungs probably because of the BALBspecific alternative splicing, which results in production of truncated protein lacking critical motifs for DNA polymerase activity (variant). This quantitative difference could account to some extent for variation in tumor susceptibility. While BALB-specific amino-acid substitutions are distributed in the C-terminal region of Polı, which does not include conserved motifs essential for DNA polymerase activity in vitro, recent studies have suggested that it contains a binding site for proliferating cell nuclear antigen that dramatically increases the polymerase activity in cooperation with replication factor C and replication protein A (Haracska et al., 2001) . Thus, it is conceivable that the amino-acid substitutions lead to defective interactions with cooperating proteins in vivo and decreased polymerase activity.
Clearly, we need to accumulate more information to evaluate the candidacy of Polı, whose physiological roles remain largely unelucidated, especially in regard to functional polymorphisms. Also, there may exist more than 10 unidentified genes within the Par2 interval. These should be satisfactorily excluded as Par2 candidates. Whatever the case, final proof of Polı identity with Par2 must be gained by production of Polı genetargeted mice and characterization of their lung tumor susceptibility.
Materials and methods
Statistical tests
Mean tumor numbers and diameters were compared by the one-sided Mann-Whitney U test, while differences in mean level of gene expression were evaluated by the two-sided Student's t-test. Proportions and correlations were examined by the one-sided versions of the binominal test and Spearman's rank correlation test, respectively. Contingency tables (2 Â 2) were analysed by the two-sided Fischer's exact test. P-values were calculated using SPSS 10J software and for all but the Student's t and Spearman's rank correlation tests, exact P-values were obtained. Multiple P-values were combined by the Stouffer method.
Animals and treatment
BALB, C3H and B6 mice were purchased from CLEA Japan, Inc. (Tokyo, Japan), while A mice were obtained from SLC Japan (Shizuoka, Japan). BALB.B6-Par2 congenic mice were supplied from our laboratory stock. This congenic strain established by 10 serial backcrosses is genetically identical to BALB except for carrying a Par2-containing, 25 cM segment of distal chromosome 18 of B6 (Lee et al., 2001) . BALB2 BALB.B6-Par2 chimeric mice were produced by combining early BALB and BALB.B6-Par2 embryos followed by implantation into pseudopregnant mothers' uteri as previously described (Lee et al., 1991) . Mice were injected i.p. with urethane (1 mg/g body weight; Sigma, St Louis, USA) or DEN (100 mg/g body weight; Wako, Osaka, Japan) at the age of 6-7 weeks to induce lung tumors. All mice were fed on basal diet (CE-II; CLEA Japan) and allowed free access to tap water throughout the experiment.
Molecular analysis of lung tumors and nontumorous lung tissues
Mice were killed under ether anesthesia and lungs were resected. For each mouse, the total number of lung tumors was enumerated under a dissecting microscope. For BALB2BALB.B6-Par2 chimeric mice, all detectable lung tumors were enucleated for genotyping and their diameters also recorded. The remnant nontumorous chimeric lung tissues were stored for determination of the congenic versus BALB cell ratio. For other mice, up to three tumors per animal were randomly sampled for Kras2 mutation analysis. Genomic DNAs were extracted from tumors and lung tissues as previously described (Lee et al., 1987) and used as templates for the PCR. Genotypes at the D18Mit49 microsatellite locus, which is linked to Par2 and polymorphic between BALB and BALB.B6-Par2, were determined by PCR with primers purchased from Research Genetics (Huntsville, AL, USA) followed by denaturing acrylamide gel electrophoresis and silver staining using the GenePhor system (Amersham Pharmacia Biotech, Little Chalfont, UK). For determination of the proportions of BALB and BALB.B6-Par2 cells in nontumorous lung tissue from each chimera, intensities of the silver-stained bands were quantitated with Image J software and the ratios of BALB and BALB.B6-Par2 alleles were calculated after normalization of allelic differences in amplification efficiency referring to the (B6 Â BALB)F 1 mouse DNA as a 1 : 1 control.
Activating point mutations of Kras2 codons 61 and 12 were analysed by a nonisotopic PCR-restriction fragment length polymorphism method as previously described (Karasaki et al., 1997) . This detects all types of activating point mutations in codons 12 and 61 reported for mouse lung tumors, although the mutation type cannot be specified for codon 12.
Physical mapping of the Par2 locus
Our previous characterization of BALB.B6-Par2 congenic mice, which are genetically identical to BALB except for carrying the Par2-containing 25 cM segment of chromosome 18 from B6, and their offspring, allowed localization of the Par2 locus within a 0.5 cM interval of distal chromosome 18 (Lee et al., 2001) . Specifically, Par2 exists between two critical recombination break points each carried by the R 7 B10 or R 7 B7 mouse originating from a BALB Â (BALB Â BALB.B6-Par2)F 1 cross. The closest proximal and distal microsatellites flanking the interval are D18Mit103 and D18Mit188, respectively. A physical map of the Par2 was built utilizing the Celera Discovery System (Celera Genomics, Rockville, MD, USA) and the sequences of PCR primers for amplification of the D18Mit103 and D18Mit188 microsatellites (Genetic and Physical Maps of the Mouse, Database Release, Center for Genome Research, Whitehead Institute/MIT).
RT-PCR-mediated sequencing of cDNAs
Total lung RNAs were extracted with Isogen (Nippon Gene, Tokyo, Japan) and treated with RNase-free DNase. cDNA templates were synthesized with random hexamer DNA primers and Superscript II RNaseH(À) reverse transcriptase (Gibco BRL, Rockville, MD, USA). For the Dcc, multiple PCR primer pairs targeting overlapping cDNA segments, each approximately 0.5 kbp in length, were designed to cover the entire open-reading frame according to their published sequences (Cooper et al., 1995) . For the Polı cDNA, the whole open-reading frame, 2.5 kbp in length (McDonald et al., 1999) was amplified using a single primer pair. Hot-start PCR was performed with the synthesized lung cDNA templates, primers and the hot-start version of Ex Taq DNA polymerase (TaKaRa, Tokyo, Japan). PCR products were directly sequenced with a Big-Dye Terminator Cycle Sequencing Ready Reaction Kit v2.0 (Applied Biosystems, Foster City, CA, USA) and an ABI3100 genetic analyser (Applied Biosystems). With regard to sequencing primers for the Polı cDNA, direct sequencing was sometimes hampered by alternative splicing. In such cases, the PCR products were TA-cloned into a plasmid vector and then sequenced as above. At least eight clones were sequenced for each PCR primer pair to rule out Taq polymerase-induced mutations in vitro. Sequences of all the primers are available on request.
Semiquantitative RT-PCR of Polı mRNAs from BALB and BALB.B6-Par2 mice Total lung RNAs were extracted from lungs of 6-week-oldmale BALB and BALB.B6-Par2 mice as mentioned above and 10 mg aliquots were used as templates for synthesizing cDNAs. PCR primers used for selective amplification of normal Polı cDNAs with 1/90 aliquots were Full-F (forward: 5 0 -ATAAC-CAGTCTGTGAACCTACA-3 0 ) and Full-R (reverse: 5 0 -CAC-TTCTGAGGAACACTTTTTA-3 0 ), resulting in a 469 bp product. Since the forward primer targets normal mRNA at the position where a 32 bp insertion occurs in variant mRNA (Figure 4) , only normal cDNA are selectively amplified. As an internal control for normalization, b2-MG cDNAs were simultaneously amplified with forward (5 0 -CTTCAGTCGT-CAGCATGGCT-3 0 ) and reverse (5 0 -GAAGGTGATGTGTA-CATTGCTA-3 0 ) primers. PCR cycles were set at 25 and 15 for Polı and b2-MG, respectively, with which all the samples were within the linear range of amplification. The annealing temperature was 571C for both primer pairs. PCR products were run on 2% agarose gels, stained with Vistra Green (Amersham Pharmacia Biotech) and band intensities were quantified with the LAS-1000 plus system (Fuji Photo Film, Tokyo, Japan).
Amounts of total Polı (normal+variant), Dcc and Mbd2 mRNAs were similarly determined with b2-MG for normalization. The sequences of PCR primers were 5 0 -AGTG-TTCCTCAGAAGTGGAAGCT-3 0 (forward) and 5 0 -ACGT-TAGGTAGCAGTCCATAGGC-3 0 (reverse) for total Polı, 5 0 -TTGGAGCAGGAAGAACTCAGTCT-3 0 (forward) and 5 0 -CATCCTGTTCATATACACTGGCTG-3 0 (reverse) for Dcc and 5 0 -GATGAATGAACAACCACGTCAGC-3 0 (forward) and 5 0 -ACAGGATGTCGGCCATCAGTGC-3 0 (reverse) for Mbd2.
Abbreviations:
A, A/J; B6, C57BL/6J; C3H, C3H/HeJ; Pas1, Pulmonary adenoma susceptibility 1; BALB, BALB/cByJ; Par2, Pulmonary adenoma resistance 2; DEN, diethylnitrosamine; PCR, polymerase chain reaction; SNP, single-nucleotide polymorphism; RT, reverse transcription; b2-MG, b2-microglobulin.
